Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Int J Radiat Biol. 2015 Nov 17;92(2):59–70. doi: 10.3109/09553002.2015.1106024

Figure 7.

Figure 7

Phase 2 TLD-based testing: Measured doses relative to 1 & 4 Gy target doses for each participating laboratory. (Plotted doses are averages of measured doses with standard deviations generally ≤ 0.05, except for SDs of 1 Gy Lab #3 value of 1.99 and 4 Gy Lab #1 value of 0.55, Lab #3 of 1.05 and Lab #7 of 0.06).